Trial Profile
Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Fludarabine (Primary) ; Lenograstim
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 02 Oct 2007 New trial record.